What does CUSIP 59102M104 represent in this 13F holders report?

CUSIP 59102M104 is the security identifier for MGX - Metagenomi Therapeutics, Inc. - COM used to aggregate holder disclosures.

How many institutions held MGX - Metagenomi Therapeutics, Inc. - COM in Q3 2025?

57 institutional investors reported MGX - Metagenomi Therapeutics, Inc. - COM for Q3 2025. Use the holders table for investor-level position and value details.

Metagenomi Therapeutics, Inc. - COM (MGX)

CUSIP: 59102M104

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class: Equity / COM
Total 13F shares: 6,000,175
Share change: -828,970
Total reported value: $14,170,933
Price per share: $2.37
Number of holders: 57
Value change: -$1,224,304
Number of buys: 20
Number of sells: 40

Quarterly Holders Quick Answers

What is CUSIP 59102M104?
CUSIP 59102M104 identifies MGX - Metagenomi Therapeutics, Inc. - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2025
Previous quarter: Q2 2025

Recent filing periods for CUSIP 59102M104:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of MGX - Metagenomi Therapeutics, Inc. - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BAYER HEALTHCARE LLC	3/4/5	10%+ Owner	— class O/S missing	4,050,997	$11,666,871	—	13 Feb 2024	3/4/5
Sebastian Bernales	3/4/5	Director	— mixed-class rows	3,147,422 mixed-class rows	$6,620,950	—	01 Apr 2024	3/4/5
Novo Holdings A/S	3/4/5	10%+ Owner	— class O/S missing	1,739,175	$5,008,824	—	09 Feb 2024	3/4/5
VANGUARD GROUP INC	13F	Company	— class O/S missing	1,257,639	$1,861,306	—	30 Jun 2025	13F
Sozo Ventures GP II, L.P.	13F	Company	— class O/S missing	581,577	$860,734	—	30 Jun 2025	13F
Catalio Capital Management, LP	13F	Company	— class O/S missing	528,993	$782,910	—	30 Jun 2025	13F
Peapod Lane Capital LLC	13F	Company	— class O/S missing	508,109	$751,990	—	30 Jun 2025	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	— class O/S missing	383,033	$566,889	—	30 Jun 2025	13F
BlackRock, Inc.	13F	Company	— class O/S missing	296,364	$438,618	—	30 Jun 2025	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	— class O/S missing	293,460	$434,320	—	30 Jun 2025	13F
PURA VIDA INVESTMENTS, LLC	13F	Company	— class O/S missing	952,134	$391,299	—	30 Jun 2025	13F
NORGES BANK	13F	Company	— class O/S missing	252,310	$373,419	—	30 Jun 2025	13F
MORGAN STANLEY	13F	Company	— class O/S missing	250,187	$370,278	—	30 Jun 2025	13F
Simon Harnest	3/4/5	Title: Chief Investment Officer and Senior Vice President of Strategy	— mixed-class rows	171,239 mixed-class rows	$353,272	—	01 Apr 2024	3/4/5
Good Life Advisors, LLC	13F	Company	— class O/S missing	200,000	$296,000	—	30 Jun 2025	13F
TANG CAPITAL MANAGEMENT LLC	13F	Company	— class O/S missing	200,000	$296,000	—	30 Jun 2025	13F
Simren Delaney	3/4/5	Title: Vice President of Intellectual Property and Legal Operations	— mixed-class rows	123,037 mixed-class rows	$270,409	—	01 Apr 2024	3/4/5
JANE STREET GROUP, LLC	13F	Company	— class O/S missing	158,931	$235,218	—	30 Jun 2025	13F
MARSHALL WACE, LLP	13F	Company	— class O/S missing	150,294	$222,434	—	30 Jun 2025	13F
Luis Borges	3/4/5	Chief Scientific Officer	— mixed-class rows	360,766 mixed-class rows	$199,630	—	01 Apr 2024	3/4/5
STATE STREET CORP	13F	Company	— class O/S missing	130,810	$193,599	—	30 Jun 2025	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	— class O/S missing	129,055	$191,002	—	30 Jun 2025	13F
Sarah B. Noonberg	3/4/5	Chief Medical Officer	— mixed-class rows	193,135 mixed-class rows	$190,986	-$9,168	06 Jun 2025	3/4/5
RENAISSANCE TECHNOLOGIES LLC	13F	Company	— class O/S missing	119,000	$176,120	—	30 Jun 2025	13F
UBS Group AG	13F	Company	— class O/S missing	118,921	$176,004	—	30 Jun 2025	13F
GOLDMAN SACHS GROUP INC	13F	Company	— class O/S missing	108,596	$160,722	—	30 Jun 2025	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	— class O/S missing	98,700	$146,076	—	30 Jun 2025	13F
WELLS FARGO & COMPANY/MN	13F	Company	— class O/S missing	98,396	$145,626	—	30 Jun 2025	13F
Resolute Advisors LLC	13F	Company	— class O/S missing	89,944	$133,117	—	30 Jun 2025	13F
RBF Capital, LLC	13F	Company	— class O/S missing	80,000	$118,400	—	30 Jun 2025	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	— class O/S missing	72,587	$107,429	—	30 Jun 2025	13F
NORTHERN TRUST CORP	13F	Company	— class O/S missing	61,832	$91,511	—	30 Jun 2025	13F
CITADEL ADVISORS LLC	13F	Company	— class O/S missing	60,624	$89,724	—	30 Jun 2025	13F
HRT FINANCIAL LP	13F	Company	— class O/S missing	59,043	$87,000	—	30 Jun 2025	13F
BBR PARTNERS, LLC	13F	Company	— class O/S missing	53,403	$79,036	—	30 Jun 2025	13F
Fortitude Advisory Group L.L.C.	13F	Company	— class O/S missing	38,490	$56,965	—	30 Jun 2025	13F
Squarepoint Ops LLC	13F	Company	— class O/S missing	38,126	$56,426	—	30 Jun 2025	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	— class O/S missing	34,169	$50,570	—	30 Jun 2025	13F
Jain Global LLC	13F	Company	— class O/S missing	28,645	$42,395	—	30 Jun 2025	13F
BROWN ADVISORY INC	13F	Company	— class O/S missing	25,006	$37,009	—	30 Jun 2025	13F
Vanguard Personalized Indexing Management, LLC	13F	Company	— class O/S missing	21,515	$31,842	—	30 Jun 2025	13F
Virtu Financial LLC	13F	Company	— class O/S missing	19,008	$28,000	—	30 Jun 2025	13F
SG Americas Securities, LLC	13F	Company	— class O/S missing	18,711	$28,000	—	30 Jun 2025	13F
Green Alpha Advisors, LLC	13F	Company	— class O/S missing	18,458	$27,318	—	30 Jun 2025	13F
Marex Group plc	13F	Company	— class O/S missing	15,000	$22,200	—	30 Jun 2025	13F
Verition Fund Management LLC	13F	Company	— class O/S missing	13,892	$20,560	—	30 Jun 2025	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	— class O/S missing	13,887	$20,553	—	30 Jun 2025	13F
PRUDENTIAL FINANCIAL INC	13F	Company	— class O/S missing	13,400	$19,832	—	30 Jun 2025	13F
Catalyst Funds Management Pty Ltd	13F	Company	— class O/S missing	12,700	$18,796	—	30 Jun 2025	13F
Tower Research Capital LLC (TRC)	13F	Company	— class O/S missing	12,375	$18,315	—	30 Jun 2025	13F

Institutional Holders of Metagenomi Therapeutics, Inc. - COM (MGX) as of Q3 2025

As of 30 Sep 2025, Metagenomi Therapeutics, Inc. - COM (MGX) was held by 57 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,000,175 shares. The largest 10 holders included VANGUARD GROUP INC, Sozo Ventures GP II, L.P., Catalio Capital Management, LP, Peapod Lane Capital LLC, MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, PURA VIDA INVESTMENTS, LLC, MORGAN STANLEY, BlackRock, Inc., and TWO SIGMA INVESTMENTS, LP. This page lists 57 institutional shareholders reporting positions in this security for the Q3 2025 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 holders

Q3 2025 holders

Holder diff

-10

Investor	Q2 2025 Shares	Q3 2025 Shares	Share Diff	Share Chg %	Q2 2025 Value $	Q3 2025 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.